Memory Assessment in Studies of Cognition-Enhancing Drugs for Alzheimer's Disease

ISSN： 1170-229X

Source： Drugs & Aging, Vol.14, Iss.3, 1999-03, pp. : 197-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cognition-Enhancing Drugs in Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD): An Update [1]

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 6, 2005-12 ,pp. : 471-487

Bentham Science Publishers

Access to resources Recommend Favorite

2-Pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs

By Scapecchi S. Martelli C. Ghelardini C. Guandalini L. Martini E. Gualtieri F.

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 715-722

Elsevier

Access to resources Recommend Favorite

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 125-138

Bentham Science Publishers

Access to resources Recommend Favorite

The Psychopharmacology of European Herbs with Cognition-Enhancing Properties

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4613-4623

Bentham Science Publishers

Access to resources Recommend Favorite

Memory-Enhancing Drugs: A Molecular Perspective

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-06 ,pp. : 769-781

Bentham Science Publishers

Access to resources Recommend Favorite